Mondelēz International reports a 14.4% increase in net revenues for fiscal year 2023, along with a gross profit increase of $2.4 million. The company points to the incremental revenue generated by the 2022 acquisitions of Clif Bar and Ricolino as helping the results. Mondelēz also registered an increase in operating income of nearly $2 million, and an operating income margin of 15.3%.
The company also saw a strong Q4 in 2023 which helped to push whole-year numbers up across the board. Net revenues in Q4 increased 7.1% year over year, with a $395 million uptick in gross profit for the quarter.
In other Mondelēz news, the company appointed Brian McNamara to its Board of Directors. McNamara has served as CEO of Haleon, formerly GSK Consumer Healthcare, since May 2022. Previously, he led GSK’s Consumer Healthcare business.
 | Mondelēz sells developed-market gum business for $1.35 billion. |
“We are pleased to welcome Brian to our Board. His breadth and depth of expertise in all aspects of consumer products leadership – including supply chain, brand marketing, customer engagement and more – will provide valuable insight and strategic input to our team,” said Dirk Van de Put, Chairman & CEO of Mondelēz International.
Before joining GSK in 2015, McNamara held a variety of senior leadership positions for several global consumer products companies, including Novartis AG and The Procter & Gamble Company. He currently sits on Haleon’s Board of Directors, as well as the Board of Directors of the Consumer Goods Forum.
McNamara’s appointment expands the size of the Company’s Board to 11 members, 10 of whom are deemed independent, including McNamara.
